63 research outputs found
Campylobacter fetus Bacteremia Revealed by Cellulitis without Gastrointestinal Symptoms in the Context of Acquired Hypogammaglobulinemia: A Report of Three Cases
Campylobacter fetus bacteremia is rare and occurs mainly in patients with immunosuppression. This infection, which often involves secondary localizations has already been reported in some primary humoral immune deficiencies. We describe three cases of severe infection due to C. fetus with cellulitis at presentation, but without any gastrointestinal symptoms, occurring in patients with acquired hypogammaglobulinemia
C. L. Downing, Salvation from Cinema: The Medium is the Message. New York and Abingdon: Routledge, 2016. Pp. viii, 196. Pb. £33.99. ISBN 978-1-138-91394-3
Review of this book on theology and film for Modern Believing
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US per capita, purchasing-power parity-adjusted US8. 8 trillion (95% uncertainty interval UI] 8.7-8.8) or 40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that 13.7 billion was targeted toward the COVID-19 health response. 1.4 billion was repurposed from existing health projects. 2.4 billion (17.9%) was for supply chain and logistics. Only 1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd
Réflexion éthique et soins palliatifs. Annonce difficile : l’exemple de l’entrée en soins palliatifs
International audienc
Réflexion éthique et soins palliatifs. Annonce difficile : l’exemple de l’entrée en soins palliatifs
International audienc
L'hospitalisation à domicile (état actuel, projets de réformes et émergence de nouvelles perspectives de carrière pour le médecin généraliste)
AIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
PSEUDOXANTHOME ELASTIQUE ET GROSSESSE (A PROPOS DE TROIS CAS)
AIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Mutation 20210 A du gène de la prothrombine et risque thrombotique (à propos de quatre cas)
AIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Marqueurs auto-immuns au cours de la drépanocytose
Nous avons évalué de façon prospective la fréquence des anticorps antinucléaires et d'anticorps aniphospholipides sur une cohorte de 18 patients porteurs d'un syndrome drépanocytaire majeur, et effectué une revue de littérature. Nous avons retrouvé une fréquence élevée d'anticorps antinucléaires sans spécificité et sans association à des signes cliniques d'auto-immunité. Quatre études de la littérature retrouvent des taux d'anticorps antinucléaires dans une population drépanocytaire plus élevés que dans une population saine.Ce n'est pas corrélé à l'activité de la drépanocytose. Il en est de même pour les anticorps antiphopholipides. Vingt-et-un cas de lupus associé à la drépanocytose ont été décrits. Il n'y a pas d'association évidente entre ces deux pathologiesAIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
- …